Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Indolizino[3,2-c]quinoline derivatives, pharmaceutically acceptable salt thereof, preparation method thereof and pharmaceutical composition for treatment of cystic fibrosis containing the same as active ingredient

US Patent 9296751 · Granted Mar 29, 2016

Assignee

Inventors

View full patent text on Google Patents →